Stock Analiz

Moderna, Inc. (MRNA) financials: revenue, earnings and cash flow

Fiscal 2016–2025 + TTM · from SEC filings · data as of November 16, 2026

Summary

Moderna’s revenue went from $108M in fiscal 2016 to $1.9B in fiscal 2025, growth of about 37.8% a year.

Net income in fiscal 2025 was -$2.8B, a net margin of -145.2%; the best year in this period was 2021 with $12.2B.

Over the twelve months to September 30, 2026, revenue was $2.5B and net income -$2.8B.

Free cash flow was -$2.1B in fiscal 2025 and positive in 4 of the 10 years shown.

The diluted share count rose 540% over the period (dilution).

Revenue, profit and cash flow by year

Revenue
2016: $108M162017: $206M172018: $135M182019: $60M192020: $803M202021: $18.5B212022: $19.3B222023: $6.8B232024: $3.2B242025: $1.9B25$1.9B
Net income
2016: -$216M162017: -$256M172018: -$385M182019: -$514M192020: -$747M202021: $12.2B212022: $8.4B222023: -$4.7B232024: -$3.6B242025: -$2.8B25-$2.8B
Free cash flow
2016: $34M162017: -$390M172018: -$437M182019: -$491M192020: $2.0B202021: $13.3B212022: $4.6B222023: -$3.8B232024: -$4.1B242025: -$2.1B25-$2.1B
EPS (diluted)
2016: $-3.79162017: $-4.18172018: $-4.95182019: $-1.55192020: $-1.96202021: $28.29212022: $20.12222023: $-12.33232024: $-9.28242025: $-7.2625$-7.26

Income statement

Fiscal yearTTM2025202420232022202120202019201820172016
Revenue$2.5B$1.9B$3.2B$6.8B$19.3B$18.5B$803M$60M$135M$206M$108M
Gross profit$707M$1.1B$1.8B$2.2B$13.8B$15.9B$795M$60M$135M——
Operating income-$2.9B-$3.1B-$3.9B-$4.2B$9.4B$13.3B-$763M-$546M-$413M-$269M-$224M
Net income-$2.8B-$2.8B-$3.6B-$4.7B$8.4B$12.2B-$747M-$514M-$385M-$256M-$216M
EPS (diluted)$-7.10$-7.26$-9.28$-12.33$20.12$28.29$-1.96$-1.55$-4.95$-4.18$-3.79
R&D$2.7B$3.1B$4.5B$4.8B$3.3B$2.0B$1.4B$496M$454M$410M$275M
Revenue growth—−39.9%−52.8%−64.5%+4.3%+2200.2%+1238.3%−55.6%−34.4%+89.9%—

Cash flow

Fiscal yearTTM2025202420232022202120202019201820172016
Operating cash flow-$1.8B-$1.9B-$3.0B-$3.1B$5.0B$13.6B$2.0B-$459M-$331M-$331M$67M
Capital spending-$185M-$192M-$1.1B-$707M-$400M-$284M-$68M-$32M-$106M-$58M-$33M
Free cash flow-$2.0B-$2.1B-$4.1B-$3.8B$4.6B$13.3B$2.0B-$491M-$437M-$390M$34M
Dividends paid—$0$0$0$0$0$0$0$0$0$0
Buybacks—$2M$0$1.2B$3.3B$857M$0$0———
Stock-based pay$464M$483M$429M$305M$226M$142M$93M$81M$73M$40M$39M

Balance sheet

Fiscal yearTTM2025202420232022202120202019201820172016
Cash—$5.8B$7.0B$8.6B$9.9B$10.7B$4.6B$1.1B$1.5B$756M$50M
Debt—$1.3B$685M$668M$127M$152M$103M$97M$71M——
Equity—$8.7B$10.9B$13.9B$19.1B$14.1B$2.6B$1.2B$1.5B-$551M-$335M
Total assets—$12.3B$14.1B$18.4B$25.9B$24.7B$7.3B$1.6B$2.0B$1.1B—
Shares (diluted)430M389M384M382M416M431M381M331M81M64M61M

Margins and returns

Fiscal yearTTM2025202420232022202120202019201820172016
Gross margin28.0%55.4%54.8%31.5%71.9%85.8%99.0%100.0%100.0%——
Operating margin-116.0%-158.1%-121.9%-61.9%48.9%72.0%-95.0%-910.0%-306.0%-130.9%-206.4%
Net margin-110.5%-145.2%-110.0%-68.8%43.4%66.1%-93.0%-856.7%-284.8%-124.3%-199.5%
FCF margin-78.0%-106.2%-125.3%-55.9%23.8%72.2%244.0%-818.3%-323.3%-189.4%31.0%
ROIC—-24.5%-33.6%-23.1%42.7%85.4%-22.6%-42.8%-20.4%——
ROE—-32.6%-32.7%-34.0%43.7%86.3%-29.2%-43.7%-25.1%46.4%64.6%

Frequently asked questions

What is Moderna’s annual revenue?

$1.9B in fiscal 2025 and $2.5B over the twelve months to September 30, 2026.

How much profit does Moderna make?

Net income was -$2.8B in fiscal 2025 (net margin -145.2%).

Is Moderna’s revenue growing?

No: revenue fell 39.9% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.